Trials / Completed
CompletedNCT05082545
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SHR-2002 Injection in Combination With SHR-1316 in Patients With Advanced Malignant Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is Phase 1 study FIH to check "Dose Escalation, Dose expansion and Indication expansion". This study is AUSTRALIA only study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-2002 and SHR-1316 | Cohort study |
Timeline
- Start date
- 2021-11-23
- Primary completion
- 2023-07-17
- Completion
- 2024-02-12
- First posted
- 2021-10-19
- Last updated
- 2024-06-04
Locations
4 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT05082545. Inclusion in this directory is not an endorsement.